Review decision – February 2018

Decision to move to the static list

The Institute was proposing that the guidance should be updated in the ongoing update of ulcerative colitis: management (NICE guideline CG166).

Responses received from stakeholders during the consultation suggested that this may not be the most appropriate course of action.

After further consideration in discussion with the developer, NICE Centre for Guidelines decided that an update of TA163 in response to new evidence would be unlikely to result in more than minor changes to the existing recommendations, and so the update has been deprioritised.

After consideration of all of the comments (attached as appendix A), the Institute’s Guidance Executive has decided that TA163 should move to the static list. 

Consequently, TA163 will not be updated and replaced in the update of CG166. Instead the recommendations will be incorporated. TA163 should move to the static list and the recommendations should remain extant.

Review decision paper

This page was last updated: